Risk of Venous Thromboembolism with Pemafibrate in Dyslipidemia: A Nationwide, Retrospective, Cohort Study Using a Japanese Claims Database
We found no increase in VTE risk associated with pemafibrate in clinical practice in Japan.
Authors
- Hideki Suganami (ORCID: https://orcid.org/0000-0001-9130-0137)
- Chieko Ishiguro (ORCID: https://orcid.org/0000-0002-1302-9430)
- Kenji Fujisawa (ORCID: https://orcid.org/0000-0001-8720-6906)
- Masaya Tanahashi
- Yoshinari Watanabe
- Kenichiro Ikeda (ORCID: https://orcid.org/0000-0002-3174-8738)
- Shun Nakano
- Kenji Yokoyama (ORCID: https://orcid.org/0000-0003-2452-7248)
- Sara Minamikawa
- Mika Tada
- Atsushi Kasano
- Takuma Tsushio
Institutions
- Kowa (Japan) (JP)
- Tokai University Hachioji Hospital (JP)
- Institute for Health Economics and Policy (JP)
Publication Details
- Journal
- Therapeutic Innovation & Regulatory Science
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1007/s43441-025-00883-y
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kowa Company